Recent Advances on Nanomaterials to COVID‐19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS‐CoV‐2 Inhibition/InactivationReview Published on 2021-02-222022-10-31 Journal: Global Challenges [Category] COVID-19, [키워드] advance agent Antiviral article assays bioactive compounds candidate Cell cell mechanisms coronavirus coronavirus disease Coronavirus disease 2019 COVID‐19 described detect Diagnosis Drug administration facial Future Health help human host inhibit main mechanism Masks measure mechanism media medication Nanocellulose Nanomaterial nanomedicine Novel coronavirus outbreak overcome pandemic Pathogenesis phytochemical Polymeric nanoparticles preventing infection public health emergency recent reduce Research retrieved review SARS‐CoV‐2 self‐cleaning surfaces Side effect silver nanoparticle Spread Surveillance systematic review therapy treat trend Vaccine Vaccines viral inactivation virucidal [DOI] 10.1002/gch2.202000115 PMC 바로가기 [Article Type] Review
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19Review Published on 2021-02-132022-10-31 Journal: Emergent Materials [Category] COVID-19, [키워드] acute respiratory syndrome approved benefit binding can be used caused component coronavirus Coronavirus 2019 CoV COVID-19 diagnose Diagnosis diagnosis of COVID-19 disease drugs effective encapsulation equipment facilitate Factor function globe greater healthcare worker investigated knowledge Lipid nanoparticles management MERS-CoV Middle East nanomedicine Nanoparticles Nanosensors Nanotechnology offer other diseases outbreak pandemic Pandemics performed pharmacological Replication Research respiratory syndrome coronavirus SARS-CoV SARS-CoV-2 severe acute respiratory syndrome Coronavirus Stage therapeutic targets therapy treat Treatment vaccination Vaccine Viral diseases [DOI] 10.1007/s42247-021-00168-8 PMC 바로가기 [Article Type] Review
Unravelling Toxoplasma treatment: conventional drugs toward nanomedicineReview Published on 2021-02-102023-06-22 Journal: World journal of microbiology & biotechnology [Category] 조류인플루엔자, [키워드] Acute toxoplasmosis Chronic toxoplasmosis Conventional therapy nanomedicine Toxoplasma gondii Treatment [DOI] 10.1007/s11274-021-03000-x [Article Type] Review
COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomesReview Published on 2021-02-032023-06-14 Journal: European journal of pharmacology [Category] MERS, SARS, [키워드] 2019-nCoV coronavirus Cytokine storm nanomedicine SARS-CoV-2 [DOI] 10.1016/j.ejphar.2021.173930 PMC 바로가기 [Article Type] Review
siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?Review Published on 2021-01-272022-10-28 Journal: Advanced Healthcare Materials [Category] COVID-19, [키워드] addition Antiviral antiviral drug antiviral drugs cause conserved COVID‐19 death develop effective emerging respiratory virus evaluated FIVE Health highlighting host gene host–viral interactions Infection inhalation inhibiting Modification nanomedicine offer outbreak pandemic Potential Prevalence Prevent prophylactically provide pulmonary pulmonary delivery Region regions Replication respiratory respiratory virus respiratory viruses resulting RNAi pathway SARS‐CoV‐1 SARS‐CoV‐2 SARS‐CoV‐2 sequence siRNA target cell target gene therapeutic use Therapeutics Treatment Vaccine viral genome viral infection viral replication viral respiratory [DOI] 10.1002/adhm.202001650 PMC 바로가기 [Article Type] Review
siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?호흡기 바이러스 감염에 대한 siRNA 치료제 - 잠재적인 COVID-19 치료제에 대해 우리는 무엇을 배웠습니까?Review Published on 2021-01-272022-09-10 Journal: Advanced Healthcare Materials [Category] 치료제, [키워드] addition Antiviral antiviral drug antiviral drugs cause choice conserved COVID‐19 death develop Economy effective emerging respiratory virus evaluated FIVE global health Health highlighting host gene host genes host–viral interactions Infection infection sites Influenza inhalation inhibiting life Modification nanomedicine offer outbreak pandemic Potential Prevalence Prevent progress report prophylactically provide pulmonary pulmonary delivery Region regions Replication respiratory respiratory virus respiratory viruses resulting RNAi pathway SARS‐CoV‐1 SARS‐CoV‐2 SARS‐CoV‐2 sequence siRNA siRNAs swine flu target cell target cells target gene therapeutic use Therapeutics Treatment Vaccine Viral viral genome viral infection viral replication viral respiratory viruses [DOI] 10.1002/adhm.202001650 PMC 바로가기 [Article Type] Review
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future ProspectsReview Published on 2021-01-222023-06-15 Journal: International journal of nanomedicine [Category] MERS, [키워드] COVID-19 drug delivery nanomedicine personalized COVID-19 management SARS-CoV-2 viral infection [DOI] 10.2147/IJN.S283686 PMC 바로가기 [Article Type] Review
Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019Review Published on 2021-01-182022-10-28 Journal: Advanced Nanobiomed Research [Category] COVID-19, [키워드] acute respiratory syndrome addressed advancement approach approved benefit caused combat Contact coronavirus coronavirus disease COVID‐19 deaths effective vaccine Exosomes expand global pandemic inactivated viruses Infectious disease investigated Lipid nanoparticles nanomedicine New Novel coronavirus offer Particles populations Prevent produced producing provide regions Safe SARS‐CoV‐2 severe acute respiratory syndrome coronavirus 2 supportive care Therapeutics Transmission Travel treat Treatment Vaccine vaccine candidate Vaccines viruses while [DOI] 10.1002/anbr.202000063 PMC 바로가기 [Article Type] Review
Current Status and Future Prospects of Perinatal Stem Cells주산기 줄기세포 현황 및 향후 전망Review Published on 2020-12-232022-09-10 Journal: Genes [Category] MERS, SARS, 임상, [키워드] Allogeneic amniotic fluid/membrane Birth Blood candidate carried Cell Cell therapy cell type cell types Characteristics chorion circulatory systems clinical settings clinical trial clinical trials contribute Cord blood COVID-19 COVID19 pneumonia current decidua described feature fetus Future gestation growth hematological immunological disorder independent individual intrinsic Mesenchymal stromal cells mother nanomedicine non-hematopoietic cell non-hematopoietic cells organ Other Pathologies Perinatal perinatal tissue perinatal tissues phenotypical Placenta Pneumonia primary source regenerative regenerative medicine status STEM stem cell stem cells stromal cell stromal cells therapeutic therapy these cell These cells tissue tissue engineering tissues treat trials umbilical cord tissue/blood unique [DOI] 10.3390/genes12010006 PMC 바로가기 [Article Type] Review
Nanotechnology in pulmonary medicineArticle Published on 2020-12-172023-06-15 Journal: Current opinion in pharmacology [Category] MERS, [키워드] Asthma COVID- 19 cystic fibrosis lung cancer Nano carrier nanomedicine Pneumonia Respiratory disease Tuberculosis [DOI] 10.1016/j.coph.2020.11.002 PMC 바로가기 [Article Type] Article